Table 1.
MDT-No | MDT-Change | MDT-Yes | Rest of Norway | ||
All UGI cancers | 2000-2004 | HR 0.96, (0.83-1.10) | HR 0.96, (0.82-1.13) | HR 0.901, (0.80-1.0) | HR 0.96, (0.83-1.11) |
2005-2008 | HR 0.96, (0.82-1.13) | HR 0.811, (0.67-0.97) | HR 0.791, (0.70-0.89) | HR 0.851, (0.77-0.93) | |
Oesophagus | 2000-2004 | HR 0.75, (0.49-1.15) | HR 1.12, (0.75-1.68) | HR 0.86, (0.63-1.17) | HR 0.89, (0.73-1.1) |
2005-2008 | HR 1.08, (0.72-1.61) | HR 0.601, (0.38-0.95) | HR 0.741, (0.53-1.02) | HR 0.84, (0.67-1.06) | |
Gastric | 2000-2004 | HR 0.94, (0.70-1.26) | HR 0.87 (0.66-1.15) | HR 0.99, (0.84-1.12) | HR 0.94, (0.70-1.25) |
2005-2008 | HR 0.94, (0.70-1.23) | HR 0.631, (0.43-0.93) | HR 0.791, (0.65-0.97) | HR 0.821, (0.70-0.95) | |
Pancreas | 2000-2004 | HR 0.97, (0.79-1.2) | HR 1.04, (0.83-1.3) | HR 0.90, (0.77-1.06) | HR 1.02, (1.02-1.03) |
2005-2008 | HR 0.92, (0.74-1.2) | HR 1.01, (0.78-1.3) | HR 0.841, (0.71-1.0) | HR 0.88, (0.78-1.0) |
UGI: Upper gastrointestinal cancer; MDT: Multidisciplinary team. Hazard ratios (HR) are given with 95% confidence interval, and the county of Oslo with MDT-Mixed serves as reference.
Statistically significant with P-value < 0.05.